HIV: a generic version of lenacapavir receives provisional approval from the FDA
Intended for 120 low- or middle-income countries, the product from Dr. Reddy’s is priced at 40 dollars per person per year. The first deliveries are expected before the end of 2026.
How sure are we
Two or more outlets reported this story and its reliability score reached 65%, so WorldPulse marks it verified. That means more than one outlet says so, not that it is proven true.
Who reported it
[Claude] Report 2 covers the same FDA approval of the generic lenacapavir for HIV, and its timing detail (supplies within weeks) is a follow-up that does not contradict Report 1's expected deliveries before en
2h agoScore bands
What moves the score
Not in the score: AI checks and reader flags. Verified is separate: two or more independent outlets and a score of at least 65%.
Very high · How we score this